{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:34:55Z","timestamp":1776180895825,"version":"3.50.1"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL)"},{"name":"Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL)"},{"name":"Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL)"},{"name":"Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL)"},{"name":"Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL)"},{"name":"Pieris AG"},{"name":"Pieris AG"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0207767","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T18:26:30Z","timestamp":1543602390000},"page":"e0207767","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Human lung tissue provides highly relevant data about efficacy of new anti-asthmatic drugs"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6860-5610","authenticated-orcid":true,"given":"Olga","family":"Danov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon Melissa","family":"Jim\u00e9nez Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Obernolte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Seehase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susann","family":"Dehmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Braubach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Gerd","family":"Fieguth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Matschiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Jonigk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-4946","authenticated-orcid":true,"given":"Sascha","family":"Knauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Pfennig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Warnecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherina","family":"Sewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"issue":"5162","key":"ref1","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.8178175","article-title":"Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations","volume":"264","author":"DG Marsh","year":"1994","journal-title":"Science"},{"issue":"14","key":"ref2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1056\/NEJM199510053331402","article-title":"Genetic susceptibility to asthma\u2014bronchial hyperresponsiveness coinherited with a major gene for atopy","volume":"333","author":"DS Postma","year":"1995","journal-title":"NEnglJ Med"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1183\/09031936.96.09050899","article-title":"Luttmann W. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts","volume":"9","author":"C Kroegel","year":"1996","journal-title":"Eur Respir J"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/rmed.2000.0826","article-title":"Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations","volume":"94","author":"J Prieto","year":"2000","journal-title":"Respir Med"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0091-6749(97)70028-9","article-title":"Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma","volume":"99","author":"M Humbert","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1002\/j.1460-2075.1993.tb05927.x","article-title":"Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction","volume":"12","author":"SM Zurawski","year":"1993","journal-title":"EMBO J"},{"issue":"5397","key":"ref7","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1126\/science.282.5397.2261","article-title":"Requirement for IL-13 independently of IL-4 in experimental asthma","volume":"282","author":"G Grunig","year":"1998","journal-title":"Science"},{"issue":"5397","key":"ref8","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1126\/science.282.5397.2258","article-title":"Interleukin-13: central mediator of allergic asthma","volume":"282","author":"M Wills-Karp","year":"1998","journal-title":"Science"},{"issue":"7280","key":"ref9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"K Moro","year":"2010","journal-title":"Nature"},{"issue":"7293","key":"ref10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"DR Neill","year":"2010","journal-title":"Nature"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1385\/CRIAI:24:1:85","article-title":"Airway hyperresponsiveness: a story of mice and men and cytokines","volume":"24","author":"RG Townley","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"issue":"46","key":"ref12","doi-asserted-by":"crossref","first-page":"29265","DOI":"10.1074\/jbc.271.46.29265","article-title":"cDNA cloning and characterization of the human interleukin 13 receptor alpha chain","volume":"271","author":"MJ Aman","year":"1996","journal-title":"J Biol Chem"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/13547500701192652","article-title":"Identification of interleukin-13 related biomarkers using peripheral blood mononuclear cells","volume":"12","author":"F Syed","year":"2007","journal-title":"Biomarkers"},{"issue":"16","key":"ref14","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"T Rhen","year":"2005","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1476-5381.2010.01199.x","article-title":"Glucocorticosteroids: current and future directions","volume":"163","author":"PJ Barnes","year":"2011","journal-title":"British journal of pharmacology"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2213-2600(16)30265-X","article-title":"Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials","volume":"4","author":"NA Hanania","year":"2016","journal-title":"The Lancet Respiratory medicine"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"J Corren","year":"2011","journal-title":"NEnglJ Med"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.200909-1448OC","article-title":"A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma","volume":"181","author":"J Corren","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"10039","key":"ref19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"S Wenzel","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1073\/pnas.96.5.1898","article-title":"Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold","volume":"96","author":"G Beste","year":"1999","journal-title":"Proc NatlAcadSci USA"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1586\/1744666X.3.4.491","article-title":"Anticalins: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies","volume":"3","author":"AM Hohlbaum","year":"2007","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"ref22","first-page":"257","article-title":"'Anticalins': a new class of engineered ligand-binding proteins with antibody-like properties","volume":"74","author":"A. Skerra","year":"2001","journal-title":"J Biotechnol"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bjp.0702394","article-title":"Characterization of airway and vascular responses in murine lungs","volume":"126","author":"HD Held","year":"1999","journal-title":"BrJ Pharmacol"},{"issue":"3","key":"ref24","first-page":"791","article-title":"Bronchoconstriction in nonhuman primates: a species comparison","volume":"111","author":"S Seehase","year":"2011","journal-title":"J ApplPhysiol"},{"issue":"1","key":"ref25","first-page":"68","article-title":"Ex vivo testing of immune responses in precision-cut lung slices","volume":"231","author":"M Henjakovic","year":"2008","journal-title":"Toxicol ApplPharmacol"},{"issue":"3","key":"ref26","first-page":"107","article-title":"Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices","volume":"246","author":"S Switalla","year":"2010","journal-title":"Toxicol ApplPharmacol"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.03.00027502","article-title":"The early allergic response in small airways of human precision-cut lung slices","volume":"21","author":"A Wohlsen","year":"2003","journal-title":"Eur Respir J"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1152\/japplphysiol.00162.2011","article-title":"Bronchoconstriction in nonhuman primates: a species comparison","volume":"111","author":"S Seehase","year":"2011","journal-title":"J Appl Physiol (1985)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1465-9921-6-50","article-title":"Multiple exposures to swine barn air induce lung inflammation and airway hyper-responsiveness","volume":"6","author":"C Charavaryamath","year":"2005","journal-title":"Respir Res"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/archotol.1986.03780030080016","article-title":"Quantitative study of goblet cells in the upper lobe of the normal human lung","volume":"112","author":"V Cerkez","year":"1986","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"L530","DOI":"10.1152\/ajplung.00133.2009","article-title":"TLR3 activation stimulates cytokine secretion without altering agonist-induced human small airway contraction or relaxation","volume":"297","author":"PR Cooper","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2006.06.004","article-title":"IL-4 induces IL-13-independent allergic airway inflammation","volume":"118","author":"C Perkins","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"L134","DOI":"10.1152\/ajplung.2001.280.1.L134","article-title":"IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils","volume":"280","author":"JJ Shim","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"L730","DOI":"10.1152\/ajplung.00089.2003","article-title":"IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation","volume":"285","author":"HC Atherton","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"ref35","first-page":"329","article-title":"Elimination of IL-13 reverses established goblet cell metaplasia into ciliated epithelia in airway epithelial cell culture","volume":"55","author":"M Kondo","year":"2006","journal-title":"AllergolInt"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1165\/ajrcmb.24.6.4301","article-title":"Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge","volume":"24","author":"N Berkman","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1398-9995.2002.5720256.x","article-title":"Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics","volume":"57","author":"T Sekiya","year":"2002","journal-title":"Allergy"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1165\/ajrcmb.25.4.4620","article-title":"Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin","volume":"25","author":"M Yang","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.molimm.2006.04.008","article-title":"Epithelial differentiation is a determinant in the production of eotaxin-2 and -3 by bronchial epithelial cells in response to IL-4 and IL-13","volume":"44","author":"WS van","year":"2007","journal-title":"Mol Immunol"},{"issue":"Suppl 3","key":"ref40","first-page":"1014","article-title":"Cultured human endometrial epithelial cells produce thymus and activation-regulated chemokine with stimulation of interleukin-4 and interleukin-13","volume":"82","author":"K Nasu","year":"2004","journal-title":"FertilSteril"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"L478","DOI":"10.1152\/ajplung.00032.2005","article-title":"Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation","volume":"289","author":"BO Abonyo","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2222.1977.tb01448.x","article-title":"Bronchial reactivity to inhaled histamine: a method and clinical survey","volume":"7","author":"DW Cockcroft","year":"1977","journal-title":"Clin Allergy"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2222.1977.tb01481.x","article-title":"Allergen-induced increase in non-allergic bronchial reactivity","volume":"7","author":"DW Cockcroft","year":"1977","journal-title":"Clin Allergy"},{"issue":"5 Pt 2","key":"ref44","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1164\/ajrccm.157.5.rsaa-2","article-title":"The physiology of small airways","volume":"157","author":"PT Macklem","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1164\/ajrccm.163.6.2007138","article-title":"Immediate allergic response in small airways","volume":"163","author":"A Wohlsen","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cell.2007.12.030","article-title":"Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4\/13 system","volume":"132","author":"SL LaPorte","year":"2008","journal-title":"Cell"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0742-8413(95)00061-5","article-title":"Characteristics of muscarinic cholinoceptors in airways of antigen-induced airway hyperresponsive rats","volume":"111","author":"Y Chiba","year":"1995","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1165\/ajrcmb.26.2.4600","article-title":"The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells","volume":"26","author":"R Venkayya","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12995-017-0158-5","article-title":"Assessment of long-term cultivated human precision-cut lung slices as an ex vivo system for evaluation of chronic cytotoxicity and functionality","volume":"12","author":"V Neuhaus","year":"2017","journal-title":"J Occup Med Toxicol"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/cyto.2000.0814","article-title":"Localization of human interleukin 13 receptor in non-haematopoietic cells","volume":"13","author":"M Akaiwa","year":"2001","journal-title":"Cytokine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.rmed.2017.12.006","article-title":"Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids","volume":"134","author":"P Korenblat","year":"2018","journal-title":"Respir Med"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.intimp.2014.05.032","article-title":"Promising future therapies for asthma","volume":"23","author":"JR Stokes","year":"2014","journal-title":"Int Immunopharmacol"},{"issue":"139","key":"ref53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1183\/16000617.0069-2015","article-title":"Future treatment for asthma","volume":"25","author":"J Charriot","year":"2016","journal-title":"Eur Respir Rev"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2014.01.002","article-title":"Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trial","volume":"133","author":"EH De Boever","year":"2014","journal-title":"The Journal of allergy and clinical immunology"},{"issue":"9","key":"ref55","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S2213-2600(15)00197-6","article-title":"Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"CE Brightling","year":"2015","journal-title":"The Lancet Respiratory medicine"},{"issue":"10","key":"ref56","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1007\/s11095-011-0481-y","article-title":"Population PK and IgE pharmacodynamic analysis of a fully human monoclonal antibody against IL4 receptor","volume":"28","author":"T Kakkar","year":"2011","journal-title":"Pharm Res"},{"issue":"26","key":"ref57","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"S Wenzel","year":"2013","journal-title":"NEnglJ Med"},{"issue":"13","key":"ref58","first-page":"1276","article-title":"Dupilumab in persistent asthma","volume":"369","author":"SE Wenzel","year":"2013","journal-title":"NEnglJ Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0207767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:36:55Z","timestamp":1589017015000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0207767"}},"subtitle":[],"editor":[{"given":"Hong Wei","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":58,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0207767","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]}}}